港股异动 | 中芯国际爆拉9%,已向美方申请继续供货华为
uSMART友信智投9月16日消息,周三港股,中芯国际盘中直线爆拉9%,截至10:11分,中芯国际涨7.98%,报21.1港元。
9月15日是华为禁令的最后期限,此后全球所有公司在向华为供应采用美国技术的产品前,都必须先向美国申请许可证。
有媒体向中芯国际求证获悉:"公司已依照规定向美方申请继续供货华为,并重申将严格遵守相关国家和地区的法律法规。"
根据媒体此前报道,已经向美国商务部提交许可申请的中外厂商还有台积电、高通、联发科、三安集成、三星显示器、SK海力士等。
值得注意的是,目前美国商务部还未向任何公司发放向华为供货的许可证。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.